Sinogen Biopharma
About:
Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.
Website: https://huajinpharmtech.com
Top Investors: Qiming Venture Partners, CHERAMI, Westlake Village BioPartners, Winzac Capital, Puxin Capital
Description:
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.
Total Funding Amount:
$13M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Contact Email:
sinogen(AT)sinogen.cc
Founders:
Zijian Zhao
Number of Employees:
Last Funding Date:
2023-12-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai